Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cigarette smoking and mortality risk in people with schizophrenia.
Kelly DL, McMahon RP, Wehring HJ, Liu F, Mackowick KM, Boggs DL, Warren KR, Feldman S, Shim JC, Love RC, Dixon L. Kelly DL, et al. Among authors: warren kr. Schizophr Bull. 2011 Jul;37(4):832-8. doi: 10.1093/schbul/sbp152. Epub 2009 Dec 17. Schizophr Bull. 2011. PMID: 20019128 Free PMC article.
Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study.
Kelly DL, Gorelick DA, Conley RR, Boggs DL, Linthicum J, Liu F, Feldman S, Ball MP, Wehring HJ, McMahon RP, Huestis MA, Heishman SJ, Warren KR, Buchanan RW. Kelly DL, et al. Among authors: warren kr. J Clin Psychopharmacol. 2011 Feb;31(1):86-91. doi: 10.1097/JCP.0b013e318204825b. J Clin Psychopharmacol. 2011. PMID: 21192149 Free PMC article. Clinical Trial.
Psychiatric symptom differences in people with schizophrenia associated with substantial lifetime substance use but no current substance use disorder.
Koola MM, Gorelick DA, McMahon RP, Liu F, Huestis MA, Linthicum J, Feldman SM, Warren KR, Wehring HJ, Kelly DL. Koola MM, et al. Among authors: warren kr. Schizophr Res. 2014 Jan;152(1):315-6. doi: 10.1016/j.schres.2013.11.035. Epub 2013 Dec 12. Schizophr Res. 2014. PMID: 24333005 Free PMC article. No abstract available.
Effects of the cannabinoid-1 receptor antagonist/inverse agonist rimonabant on satiety signaling in overweight people with schizophrenia: a randomized, double-blind, pilot study.
Warren KR, Buchanan RW, Feldman S, Conley RR, Linthicum J, Ball MP, Liu F, McMahon RP, Gorelick DA, Huestis MA, Kelly DL. Warren KR, et al. J Clin Psychopharmacol. 2013 Feb;33(1):118-20. doi: 10.1097/JCP.0b013e3182793843. J Clin Psychopharmacol. 2013. PMID: 23277241 Free PMC article. Clinical Trial. No abstract available.
49 results